Project Details
Description
A Multicenter, Open-Label, Randomized, Phase II/III Study to Evaluate the Safety and Efficacy of Combretastatin A-4 Phosphate
| Status | Finished |
|---|---|
| Effective start/end date | 6/21/07 → 10/3/11 |
Funding
- Oxigene, Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.